All In MedTech

Device Trial Radar · NCT02936622

Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses

Last checked: Nov 20, 2026Latest source record: Apr 5, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 176 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

176

Actual

Start

Feb 21, 2017

Primary completion

Apr 23, 2019

Study completion Oct 25, 2023

Sponsor

Lead sponsor
Cook Group IncorporatedNot on our public-company list
Sponsor type
Industry
First posted
Oct 18, 2016

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This randomized multi-center study is intended to compare different coatings on stents for treatment of lesions of the above-the-knee femoropopliteal artery.

Conditions

  • Peripheral Arterial Disease (PAD)

Interventions

  • Zilver® Paclitaxel-Eluting Peripheral StentDevice

    Paclitaxel belongs to the Taxane drug class and coated on the stent at a much lower dose than when administered as a chemotherapy agent.

  • Zilver® Paclitaxel-Eluting Peripheral Stent with slower-dissolving polymer-free paclitaxel coatingDevice

    Paclitaxel belongs to the Taxane drug class and coated on the stent at a much lower dose than when administered as a chemotherapy agent.

  • Zilver® Paclitaxel-Eluting Peripheral Stent with higher-dose polymer-free paclitaxel coatingDevice

    Paclitaxel belongs to the Taxane drug class and coated on the stent at a much lower dose than when administered as a chemotherapy agent.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The percent diameter stenosis within the study lesion evaluated by conventional angiography.Time frame: 6 months

Locations

11 sites in 2 countries. Site status is shown where the registry gives one.

  • Klinikum Hochsauerland

    Arnsberg, Germany

  • Universitäts Herzzentrum Freiburg - Bad Krozingen

    Bad Krozingen, Germany

  • Krankenhaud Bucholz

    Buchholz, Germany

8 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.